Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon Cancer By Ogkologos - July 30, 2026 143 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CIRCULATE, an AIO (KRK-0217)/ABCSG study Source RELATED ARTICLESMORE FROM AUTHOR Adding Abiraterone to ADT and Docetaxel Improves Survival in Metastatic Prostate Cancer A glucometer for cancer: towards a scalable, universal residual disease measurement Consensus-Defined Weight Loss Episodes Arise in Discrete Intervals, Are Enriched Around Progression and Associated with Serologic Signatures and Somatic Tumour Genotypes MOST POPULAR Therapy Rottweiler, known as Dogtor Loki, Is Delivering ‘Hero Healing Kits’... April 16, 2020 A radical project: video game design meets cancer research December 1, 2022 Silence Speaks Volumes June 16, 2020 ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large... April 16, 2015 Load more HOT NEWS How repurposing a drug in a COVID-19 trial could benefit people... Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom... Epcoritamab Shows a Manageable Safety and Robust Antitumour Activity in Heavily... New ESMO Framework to Resolve Uncertainties About the De-intensification of Cancer...
